Abstract
Necrotizing soft tissue infection (NSTI) is a rare disease primarily affecting middle- and older-aged individuals. No predisposing risk factor is identified in a high percentage of patients. Mortality rates have not improved significantly over the past century. Amputation rates are high and multiple debridements are the rule. Wide surgical debridement is the only effective therapy for NSTI and that time is of the utmost essence. Mortality remains between 10 and 30 % and long-term disability is common.
Similar content being viewed by others
References
Descamps V, Aitken J, Lee MG. Hippocrates on necrotising fasciitis. Lancet. 1994;344(8921):556.
Paré A, Johnson T. The workes of the famous Chururgian Ambrose Parey, 1575 translated from the Latin by Johnson. London: Cotes and Young; 1634.
Salcido RS. Necrotizing fasciitis: reviewing the causes and treatment strategies. Adv Skin Wound Care. 2007; 20(5):288–93; quiz 294–5.
Green RJ, Dafoe DC, Raffin TA. Necrotizing fasciitis. Chest. 1996;110(1):219–29.
Phan HH, Cocanour CS. Necrotizing soft tissue infections in the intensive care unit. Crit Care Med. 2010;38(9 Suppl):S460–8.
Quirk Jr WF, Sternbach G. Joseph Jones: infection with flesh eating bacteria. J Emerg Med. 1996;14(6):747–53.
Meleney F. Hemolytic streptococcus gangrene. Arch Surg. 1924;9:317–64.
May AK. Skin and soft tissue infections. Surg Clin North Am. 2009;89(2):403–20,viii.
Anaya DA, Dellinger EP. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis. 2007;44(5):705–10.
Kaul R et al. Population-based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario group A Streptococcal Study. Am J Med. 1997;103(1):18–24.
Das DK, Baker MG, Venugopal K. Increasing incidence of necrotizing fasciitis in New Zealand: a nationwide study over the period 1990 to 2006. J Infect. 2011;63(6):429–33.
Soltani AM et al. Trends in the incidence and treatment of necrotizing soft tissue infections: an analysis of the National Hospital Discharge Survey. J Burn Care Res. 2014;35(5):449–54.
Mills MK, et al. Outcomes from treatment of necrotizing soft-tissue infections: results from the National Surgical Quality Improvement Program database. Am J Surg. 2010; 200(6):790–6; discussion 796–7.
McHenry CR, et al. Determinants of mortality for necrotizing soft-tissue infections. Ann Surg. 1995;221(5):558–63; discussion 563–5.
Elliott D, Kufera JA, Myers RA. The microbiology of necrotizing soft tissue infections. Am J Surg. 2000;179(5):361–6.
Su YC et al. Laboratory risk indicator for necrotizing fasciitis score and the outcomes. ANZ J Surg. 2008;78(11):968–72.
Zacharias N et al. Diagnosis of necrotizing soft tissue infections by computed tomography. Arch Surg. 2010;145(5):452–5.
Wall DB et al. A simple model to help distinguish necrotizing fasciitis from nonnecrotizing soft tissue infection. J Am Coll Surg. 2000;191(3):227–31.
Kao LS et al. Local variations in the epidemiology, microbiology, and outcome of necrotizing soft-tissue infections: a multicenter study. Am J Surg. 2011;202(2):139–45.
Huang KF, et al. Independent predictors of mortality for necrotizing fasciitis: a retrospective analysis in a single institution. J Trauma. 2011;71(2):467–73; discussion 473.
Mulla ZD, Gibbs SG, Aronoff DM. Correlates of length of stay, cost of care, and mortality among patients hospitalized for necrotizing fasciitis. Epidemiol Infect. 2007;135(5):868–76.
Singh G et al. Necrotising infections of soft tissues–a clinical profile. Eur J Surg. 2002;168(6):366–71.
Anaya DA, et al. Predictors of mortality and limb loss in necrotizing soft tissue infections. Arch Surg. 2005;140(2):151–7; discussion 158.
Childers BJ et al. Necrotizing fasciitis: a fourteen-year retrospective study of 163 consecutive patients. Am Surg. 2002;68(2):109–16.
Wong CH et al. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am. 2003;85-A(8):1454–60.
Brandt MM, Corpron CA, Wahl WL. Necrotizing soft tissue infections: a surgical disease. Am Surg. 2000;66(10):967–70; discussion 970–1.
Hsiao CT et al. Predictors of mortality in patients with necrotizing fasciitis. Am J Emerg Med. 2008;26(2):170–5.
Yilmazlar T et al. Necrotizing soft tissue infections: APACHE II score, dissemination, and survival. World J Surg. 2007;31(9):1858–62.
Endorf FW, Supple KG, Gamelli RL. The evolving characteristics and care of necrotizing soft-tissue infections. Burns. 2005;31(3):269–73.
Hakkarainen TW et al. Moving beyond survival as a measure of success: understanding the patient experience of necrotizing soft-tissue infections. J Surg Res. 2014;192(1):143–9.
Light TD et al. Long-term outcomes of patients with necrotizing fasciitis. J Burn Care Res. 2010;31(1):93–9.
Kobayashi L et al. Necrotizing soft tissue infections: delayed surgical treatment is associated with increased number of surgical debridements and morbidity. J Trauma. 2011;71(5):1400–5.
Bosshardt TL, Henderson VJ, Organ Jr CH. Necrotizing soft-tissue infections. Arch Surg. 1996;131(8):846–52; discussion 852–4.
Liu YM et al. Microbiology and factors affecting mortality in necrotizing fasciitis. J Microbiol Immunol Infect. 2005;38(6):430–5.
Pessa ME, Howard RJ. Necrotizing fasciitis. Surg Gynecol Obstet. 1985;161(4):357–61.
Elliott DC, Kufera JA, Myers RA. Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. Ann Surg. 1996;224(5):672–83.
Anaya DA et al. Predicting death in necrotizing soft tissue infections: a clinical score. Surg Infect (Larchmt). 2009;10(6):517–22.
Tillou A et al. Necrotizing soft tissue infections: improved outcomes with modern care. Am Surg. 2004;70(10):841–4.
Lee CC et al. Necrotizing fasciitis in patients with liver cirrhosis: predominance of monomicrobial Gram-negative bacillary infections. Diagn Microbiol Infect Dis. 2008;62(2):219–25.
Keung EZ et al. Immunocompromised status in patients with necrotizing soft-tissue infection. JAMA Surg. 2013;148(5):419–26.
Sorensen MD et al. Fournier's gangrene: management and mortality predictors in a population based study. J Urol. 2009;182(6):2742–7.
Bernal NP et al. Trends in 393 necrotizing acute soft tissue infection patients 2000-2008. Burns. 2012;38(2):252–60.
Eggerstedt M, Gamelli RL, Mosier MJ. The care of necrotizing soft-tissue infections: patterns of definitive intervention at a large referral center. J Burn Care Res. 2015;36(1):105–10.
Lee TC, et al. Incidence and clinical characteristics of methicillin-resistant Staphylococcus aureus necrotizing fasciitis in a large urban hospital. Am J Surg. 2007;194(6): 809–12; discussion 812–3.
Sarani B et al. Necrotizing fasciitis: current concepts and review of the literature. J Am Coll Surg. 2009;208(2):279–88.
Voros D et al. Role of early and extensive surgery in the treatment of severe necrotizing soft tissue infection. Br J Surg. 1993;80(9):1190–1.
Wong CH, Wang YS. The diagnosis of necrotizing fasciitis. Curr Opin Infect Dis. 2005;18(2):101–6.
Chao WN et al. Impact of timing of surgery on outcome of Vibrio vulnificus-related necrotizing fasciitis. Am J Surg. 2013;206(1):32–9.
Ahmad A, Brumble L, Maniaci M. Vibrio parahaemolyticus Induced Necrotizing Fasciitis: An Atypical Organism Causing an Unusual Presentation. Case Rep Infect Dis. 2013;2013:216854.
NIH. Highly invasive new bacterium isolated from US east coast waters. JAMA. 1984;251(3):323–5.
Cainzos M, Gonzalez-Rodriguez FJ. Necrotizing soft tissue infections. Curr Opin Crit Care. 2007;13(4):433–9.
Stone DR, Gorbach SL. Necrotizing fasciitis. The changing spectrum. Dermatol Clin. 1997;15(2):213–20.
Miller LG et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med. 2005;352(14):1445–53.
Dunbar NM, Harruff RC. Necrotizing fasciitis: manifestations, microbiology and connection with black tar heroin. J Forensic Sci. 2007;52(4):920–3.
Bonifaz A et al. Primary cutaneous mucormycosis produced by the new species Apophysomyces mexicanus. J Clin Microbiol. 2014;52(12):4428–31.
Echaiz JF, Burnham CA, Bailey TC. A case of Apophysomyces trapeziformis necrotizing soft tissue infection. Int J Infect Dis. 2013;17(12):e1240–2.
Buchanan PJ et al. Candida albicans necrotizing soft tissue infection: a case report and literature review of fungal necrotizing soft tissue infections. Ann Plast Surg. 2013;70(6):739–41.
Carr L et al. Scedosporium: an unlikely cause of fungal necrotizing fasciitis. Am Surg. 2015;81(6):E253–4.
Patel SS et al. Necrotizing soft tissue infection occurring after exposure to mycobacterium marinum. Case Rep Infect Dis. 2014;2014:702613.
Martinschek A et al. Prognostic aspects, survival rate, and predisposing risk factors in patients with Fournier’s gangrene and necrotizing soft tissue infections: evaluation of clinical outcome of 55 patients. Urol Int. 2012;89(2):173–9.
Eke N. Fournier’s gangrene: a review of 1726 cases. Br J Surg. 2000;87(6):718–28.
Tovi F, Fliss DM, Zirkin HJ. Necrotizing soft-tissue infections in the head and neck: a clinicopathological study. Laryngoscope. 1991;101(6 Pt 1):619–25.
Maisel RH, Karlen R. Cervical necrotizing fasciitis. Laryngoscope. 1994;104(7):795–8.
Hsieh RL, Huang CH, Uen WC. Necrotizing fasciitis after acupuncture in a patient with aplastic anemia. J Altern Complement Med. 2011;17(9):871–4.
Rea WJ, Wyrick Jr WJ. Necrotizing fasciitis. Ann Surg. 1970;172(6):957–64.
Brook I, Frazier EH. Clinical and microbiological features of necrotizing fasciitis. J Clin Microbiol. 1995;33(9):2382–7.
Yen ZS et al. Ultrasonographic screening of clinically-suspected necrotizing fasciitis. Acad Emerg Med. 2002;9(12):1448–51.
Oelze L, Wu S, Carnell J. Emergency ultrasonography for the early diagnosis of necrotizing fasciitis: a case series from the ED. Am J Emerg Med. 2013;31(3):632 e5–7.
Butcher CH, Dooley RW, Levitov AB. Detection of subcutaneous and intramuscular air with sonography: a sensitive and specific modality. J Ultrasound Med. 2011;30(6):791–5.
McGillicuddy EA et al. Development of a computed tomography-based scoring system for necrotizing soft-tissue infections. J Trauma. 2011;70(4):894–9.
Carbonetti F et al. The role of contrast enhanced computed tomography in the diagnosis of necrotizing fasciitis and comparison with the laboratory risk indicator for necrotizing fasciitis (LRINEC). Radiol Med. 2016;121:106–21.
Schmid MR, Kossmann T, Duewell S. Differentiation of necrotizing fasciitis and cellulitis using MR imaging. AJR Am J Roentgenol. 1998;170(3):615–20.
Kim KT et al. Can necrotizing infectious fasciitis be differentiated from nonnecrotizing infectious fasciitis with MR imaging? Radiology. 2011;259(3):816–24.
Brothers TE et al. Magnetic resonance imaging differentiates between necrotizing and non-necrotizing fasciitis of the lower extremity. J Am Coll Surg. 1998;187(4):416–21.
Wong CH et al. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004;32(7):1535–41.
Holland MJ. Application of the Laboratory Risk Indicator in Necrotising Fasciitis (LRINEC) score to patients in a tropical tertiary referral centre. Anaesth Intensive Care. 2009;37(4):588–92.
Tsai YH et al. Laboratory indicators for early detection and surgical treatment of vibrio necrotizing fasciitis. Clin Orthop Relat Res. 2010;468(8):2230–7.
Wilson MP, Schneir AB. A case of necrotizing fasciitis with a LRINEC score of zero: clinical suspicion should trump scoring systems. J Emerg Med. 2013;44(5):928–31.
Edlich RF et al. Modern concepts of the diagnosis and treatment of necrotizing fasciitis. J Emerg Med. 2010;39(2):261–5.
Stamenkovic I, Lew PD. Early recognition of potentially fatal necrotizing fasciitis. The use of frozen-section biopsy. N Engl J Med. 1984;310(26):1689–93.
Okoye O et al. Timing of redebridement after initial source control impacts survival in necrotizing soft tissue infection. Am Surg. 2013;79(10):1081–5.
Friederichs J et al. Procalcitonin ratio as a predictor of successful surgical treatment of severe necrotizing soft tissue infections. Am J Surg. 2013;206(3):368–73.
Heinle EC et al. The use of 5 % mafenide acetate solution in the postgraft treatment of necrotizing fasciitis. J Burn Care Rehabil. 2001;22(1):35–40.
Stevens DL et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005;41(10):1373–406.
Jallali N, Withey S, Butler PE. Hyperbaric oxygen as adjuvant therapy in the management of necrotizing fasciitis. Am J Surg. 2005;189(4):462–6.
Sheridan RL, Shank ES. Hyperbaric oxygen treatment: a brief overview of a controversial topic. J Trauma. 1999;47(2):426–35.
Van U. Inhibition of toxin production in clostridium perfringens in vitro by hyperbaric oxygen. Antonie Van Leeuwenhoek. 1965;31:181–6.
Wilkinson D, Doolette D. Hyperbaric oxygen treatment and survival from necrotizing soft tissue infection. Arch Surg. 2004;139(12):1339–45.
Riseman JA et al. Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements. Surgery. 1990;108(5):847–50.
Escobar SJ et al. Adjuvant hyperbaric oxygen therapy (HBO2)for treatment of necrotizing fasciitis reduces mortality and amputation rate. Undersea Hyperb Med. 2005;32(6):437–43.
Soh CR et al. Hyperbaric oxygen therapy in necrotising soft tissue infections: a study of patients in the United States Nationwide Inpatient Sample. Intensive Care Med. 2012;38:1143–51.
Shaw JJ et al. Not just full of hot air: hyperbaric oxygen therapy increases survival in cases of necrotizing soft tissue infections. Surg Infect (Larchmt). 2014;15(3):328–35.
Massey PR et al. Hyperbaric oxygen therapy in necrotizing soft tissue infections. J Surg Res. 2012;177(1):146–51.
Brown DR et al. A multicenter review of the treatment of major truncal necrotizing infections with and without hyperbaric oxygen therapy. Am J Surg. 1994;167(5):485–9.
Shupak A et al. Necrotizing fasciitis: an indication for hyperbaric oxygenation therapy? Surgery. 1995;118(5):873–8.
George ME et al. Hyperbaric oxygen does not improve outcome in patients with necrotizing soft tissue infection. Surg Infect (Larchmt). 2009;10(1):21–8.
Darenberg J et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2003;37(3):333–40.
Kaul R et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome–a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis. 1999;28(4):800–7.
Norrby-Teglund A et al. Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach. Scand J Infect Dis. 2005;37(3):166–72.
Bulger EM et al. A novel drug for treatment of necrotizing soft-tissue infections: a randomized clinical trial. JAMA Surg. 2014;149:528–36.
Bulger EM et al. Impact and progression of organ dysfunction in patients with necrotizing soft tissue infections: a multicenter study. Surg Infect (Larchmt). 2015;16:694–701.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Yeh, D.D., Velmahos, G. (2017). Necrotizing Soft Tissue Infections. In: Luchette, F., Yelon, J. (eds) Geriatric Trauma and Critical Care. Springer, Cham. https://doi.org/10.1007/978-3-319-48687-1_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-48687-1_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-48685-7
Online ISBN: 978-3-319-48687-1
eBook Packages: MedicineMedicine (R0)